Furthermore, a 2007 study assessed the ability of a statistical model to analyze protein expression levels of EGFR and HER2 in response to lapatinib in 61 different human tumor cell lines from 12 tumor types, two oncogene transformed human cell lines, and two normal human cell cultures. The gene discussed is ERBB2; the disease is neoplasm.